Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950109-02-004130
Filing Date
2002-08-14
Accepted
2002-08-13 17:31:51
Documents
3
Period of Report
2001-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A d10ka.htm 10-K/A 746967
3 PRICEWATERHOUSECOOPERS CONSENT dex231.htm EX-23.1 1501
4 CONSENT OF CHARTERED ACCOUNTANTS dex232.htm EX-23.2 1669
  Complete submission text file 0000950109-02-004130.txt   752025
Mailing Address PO BOX 14287 RESEARCH TRIANGLE PK NC 27709
Business Address 79 T.W. ALEXANDER DRIVE 4401 RESEARCH COMMONS- SUITE 200 RESEARCH TRIANGLE PK NC 27709 9195588688
INCARA PHARMACEUTICALS CORP (Filer) CIK: 0000936538 (see all company filings)

EIN.: 561924222 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-K/A | Act: 34 | File No.: 000-27410 | Film No.: 02730943
SIC: 2834 Pharmaceutical Preparations